Alcon projects sales growth and margin expansion for 2026 driven by new product launches
Alcon expects 2026 sales growth and margin expansion via new product launches. Steady demand for cataract surgery helps offset rising tariff costs globally.
Insights:
Alcon Inc. , the eye-care specialist based in Switzerland 
CH, announced its financial guidance for 2026 today, forecasting constant-currency sales growth in the range of 5% to 7%. Alongside this revenue outlook, the company guided for a significant expansion in its operating margin, attributing the expected growth to the continued rollout and adoption of its latest surgical platforms and contact lenses.
CH, announced its financial guidance for 2026 today, forecasting constant-currency sales growth in the range of 5% to 7%. Alongside this revenue outlook, the company guided for a significant expansion in its operating margin, attributing the expected growth to the continued rollout and adoption of its latest surgical platforms and contact lenses.
